DA
BLUE

Denali Advisors’s bluebird bio BLUE Stock Holding History

Denali Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-480
Closed -$66.4K – 443
2022
Q4 		$66.4K Sell
480
-570
-54% -$80.3K 0.03% 196
2022
Q3 		$133K Sell
1,050
-225
-18% -$25.5K 0.06% 153
2022
Q2 		$106K Buy
1,275
+770
+152% +$59.7K 0.05% 171
2022
Q1 		$49K Hold
505
– – 0.02% 241
2021
Q4 		$101K Buy
+505
New +$119K 0.04% 192

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Denali Advisors's BLUE Position: Q1 2023 in Review

Denali Advisors sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 480 shares — an estimated $66.4K sold.

Denali Advisors first reported a position in BLUE in Q4 2021 and held it in 5 quarters. The position peaked at $133K in Q3 2022. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Denali Advisors reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Denali Advisors sold 480 bluebird bio shares in Q1 2023, an estimated $66.4K.
  • Denali Advisors first reported a position in bluebird bio in Q4 2021 and held it in 5 quarters.
  • Denali Advisors's bluebird bio position peaked at $133K in Q3 2022.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Denali Advisors's 13F filing for Q1 2023, filed 21 Apr 2023.